Zomedica Corp. (ZOMDF) — 10-Q Filings

10-Q Filings (6)

• Zomedica's Net Loss Doubles Amidst $55.8M Impairment Charge — Nov 4, 2025 Risk: high
  Zomedica Corp. reported a net loss of $77.328 million for the nine months ended September 30, 2025, a significant increase from the $39.788 million net loss in
• Zomedica Narrows Losses, Revenue Up 15.9% in Q2 — Aug 6, 2025 Risk: medium
  Zomedica Corp. reported its Q2 2025 results, showing a net loss of $3.5 million for the three months ended June 30, 2025, a decrease from a net loss of $4.2 mil
• Zomedica Corp. Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  Zomedica Corp. filed its 10-Q for the period ending March 31, 2025. The company, headquartered in Ann Arbor, MI, is involved in the pharmaceutical preparations
• Zomedica Corp. Files Q3 2024 10-Q — Nov 7, 2024 Risk: medium
  Zomedica Corp. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on its business operatio
• Zomedica Corp. Files Q2 2024 10-Q — Aug 14, 2024 Risk: medium
  Zomedica Corp. filed its 10-Q for the period ending June 30, 2024. The company, headquartered in Ann Arbor, MI, operates in the pharmaceutical preparations sect
• Zomedica Corp. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: medium
  Zomedica Corp. (ZOMDF) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Zomedica Corp. filed its 10-Q report for the quarterly period ended March 31

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX